{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:44:37Z","timestamp":1791391477360,"version":"4.3.3"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,7,29]],"date-time":"2020-07-29T00:00:00Z","timestamp":1595980800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,7,29]],"date-time":"2020-07-29T00:00:00Z","timestamp":1595980800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1208\/s12249-020-01751-8","type":"journal-article","created":{"date-parts":[[2020,7,29]],"date-time":"2020-07-29T16:04:00Z","timestamp":1596038640000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Development and Stability Control of Pediatric Oral Tizanidine Hydrochloride Formulations for Hospital Use"],"prefix":"10.1208","volume":"21","author":[{"given":"Caren","family":"Gobetti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Eduarda","family":"Balsan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e1rcio Vin\u00edcius","family":"Ayres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00edlvia Helena Oliveira","family":"de Almeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"de Saldanha Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie Ribeiro","family":"Wingert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T\u00e9rcio Paschke","family":"Oppe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e1ssia Virginia","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,29]]},"reference":[{"key":"1751_CR1","unstructured":"The Japanese Pharmacopoeia. 16th edn. 2011."},{"key":"1751_CR2","volume-title":"Martindale: the complete drug reference","author":"SC Sweetman","year":"2011","unstructured":"Sweetman SC. Martindale: the complete drug reference. London: Pharmaceutical Press; 2011."},{"key":"1751_CR3","unstructured":"USP 38. The United States Pharmacopoeia. 38 edn. Rockville, MD; 2015."},{"key":"1751_CR4","unstructured":"Murthy TK, Reddy MN, Sankar DG. UV spectrophotomeric methods for the determinations of celecoxib and tizanidine hydrochloride. Indian J Pharm Sci. 2001:521\u20133."},{"key":"1751_CR5","first-page":"403","volume":"3","author":"S Paladugu","year":"2013","unstructured":"Paladugu S, Divakar B, Rama HB, Ramu A, Mahesh U. Development and validation of new analytical method for the estimation of tizanidine hydrochloride in bulk and in formulation by UV spectrophotometric method. Int J Pharma Sci. 2013;3:403\u20137.","journal-title":"Int J Pharma Sci"},{"key":"1751_CR6","first-page":"96","volume":"1","author":"L Sivasubramanian","year":"2009","unstructured":"Sivasubramanian L, Devarajan L. Spectrophotometric and HPLC methods for simultaneous estimation of tizanidine and valdecoxib from tablets. Int J ChemTech Res. 2009;1:96\u2013102.","journal-title":"Int J ChemTech Res"},{"key":"1751_CR7","first-page":"519","volume":"65","author":"K Sujatha","year":"2003","unstructured":"Sujatha K, Chitra K, Hettiarachchi DS, Krishna MV, Vasantha J. Spectophotometric determination of tizanidine hydrochloride. Indian J Pharm Sci. 2003;65:519\u201320.","journal-title":"Indian J Pharm Sci"},{"key":"1751_CR8","first-page":"46","volume":"1","author":"MD Dhanaraju","year":"2010","unstructured":"Dhanaraju MD, Varma DP, Magesh AR, Gunasekaran V. RP-HPLC method for the simultaneous estimation of rofecoxib and tizanidine hydrochloride in bulk and pharmaceutical dosage form. Int J Biopharm. 2010;1:46\u201350.","journal-title":"Int J Biopharm"},{"key":"1751_CR9","first-page":"1212","volume":"5","author":"PB Dudhe","year":"2013","unstructured":"Dudhe PB, Jadhav S, Sawarkar V, Nagras MA. Method development and validation for simultaneous determination of aceclofenac and tizanidine in bulk and marketed formulation. Int J Pharmtech Res. 2013;5:1212\u20136.","journal-title":"Int J Pharmtech Res"},{"key":"1751_CR10","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.jpba.2004.09.039","volume":"37","author":"M Gandhimathi","year":"2005","unstructured":"Gandhimathi M, Ravi TK, Varguese SJ. Simultaneous LC determination of tizanidine and rofecoxib in tablets. J Pharm Biomed Anal. 2005;37:183\u20135.","journal-title":"J Pharm Biomed Anal"},{"key":"1751_CR11","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.jpba.2004.09.036","volume":"37","author":"N Kaul","year":"2005","unstructured":"Kaul N, Dhaneshwar SR, Agrawal H, Kakad A, Patil B. Application of HPLC and HPTLC for simultaneous determination of tizanidine and rofecoxib in pharmaceutical dosage form. J Pharmaceut Biomed. 2005;37:27\u201338.","journal-title":"J Pharmaceut Biomed"},{"key":"1751_CR12","first-page":"84","volume":"2","author":"RS Kumar","year":"2010","unstructured":"Kumar RS, Nathan PS, Nallasivan PK, Solomon WDS, Venkatnarayanan R. A validated reversed phase HPLC-method for the determination of aceclofenac and tizanidine in tablets. JPRHC. 2010;2:84\u201394.","journal-title":"JPRHC"},{"key":"1751_CR13","first-page":"111","volume":"2","author":"BN Nalluri","year":"2012","unstructured":"Nalluri BN, Sushmitha K, Sunandana B, Badu DP. Development and validation of RP-HPLC-PDA method for simultaneous estimation of baclofen and tizanidine in bulk and dosage forms. J Appl Pharm Sci. 2012;2:111\u20136.","journal-title":"J Appl Pharm Sci"},{"key":"1751_CR14","doi-asserted-by":"publisher","first-page":"2","DOI":"10.4172\/2155-9872.1000123","volume":"2","author":"C NarajjI","year":"2011","unstructured":"NarajjI C, Patel HR, Karvekar MD, Suresh BAR. Simultaneous estimation of aceclofenac, paracetamol and tizanidine in their combined dosage forms by spectrophotometric and RP-HPLC method. J Anal Bioanal Tech. 2011;2:2\u20134.","journal-title":"J Anal Bioanal Tech"},{"key":"1751_CR15","doi-asserted-by":"publisher","first-page":"281","DOI":"10.4103\/0250-474X.33158","volume":"69","author":"H Nimje","year":"2007","unstructured":"Nimje H, Wate SP, Dharkar DP, Razdan R. Simultaneous RPHPLC determination of nimesulide and tizanidine in tablets. Indian J Pharm Sci. 2007;69:281\u20133.","journal-title":"Indian J Pharm Sci"},{"key":"1751_CR16","doi-asserted-by":"publisher","first-page":"670","DOI":"10.4103\/0250-474X.29647","volume":"68","author":"M Puranik","year":"2006","unstructured":"Puranik M, Wadher SJ, Dhole S, Yeole PG. Simultaneous estimation of valdecoxib and tizanidine hydrochloride in tablets by RP-HPLC. Indian J Pharm Sci. 2006;68:670\u20132.","journal-title":"Indian J Pharm Sci"},{"key":"1751_CR17","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/S0003-2670(02)01525-8","volume":"478","author":"ML Qi","year":"2002","unstructured":"Qi ML, Wang P, Wang L. Validated liquid chromatography method for assay of tizanidine in drug substance and formulated product. Anal Chim Acta. 2002;478:171\u20137.","journal-title":"Anal Chim Acta"},{"key":"1751_CR18","doi-asserted-by":"publisher","first-page":"514","DOI":"10.4103\/0250-474X.27832","volume":"68","author":"CS Ramaa","year":"2006","unstructured":"Ramaa CS, Deshpande DK, Shirode AR, Wamorkar VV, Kakad AB, Kadam VJ. Reserve-phase high performance liquid chromatographic determination of tizanidine and valdecoxib in tablets. Indian J Pharm Sci. 2006;68:514\u20136.","journal-title":"Indian J Pharm Sci"},{"key":"1751_CR19","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1155\/2010\/323410","volume":"7","author":"VV Vaidya","year":"2010","unstructured":"Vaidya VV, Singh GR, Choukekar MP, Kekare MB. Simultaneous RP HPLC determination of aceclofenac, paracetamol and tizanidine in pharmaceutical preparations. E-J Chem. 2010;7:260\u20134.","journal-title":"E-J Chem"},{"key":"1751_CR20","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/S0731-7085(03)00304-2","volume":"33","author":"KR Mahadik","year":"2003","unstructured":"Mahadik KR, Paradkar AR, Agrawal H, Kaul N. Stability-indicating HPTLC determination of tizanidine hydrochloride in bulk drug and pharmaceutical formulations. J Pharmaceut Biomeds. 2003;33:545\u201352.","journal-title":"J Pharmaceut Biomeds"},{"key":"1751_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/7463914","volume":"2018","author":"S Bawazeer","year":"2018","unstructured":"Bawazeer S, Badr El-Din KM, Abdel-Megied AM. Development and validation of a versatile UPLC-PDA method for simultaneous determination of paracetamol, tizanidine, aceclofenac, and nimesulide in their new combinations. J Anal Methods Chem. 2018;2018:1\u20137.","journal-title":"J Anal Methods Chem"},{"key":"1751_CR22","doi-asserted-by":"publisher","first-page":"2286","DOI":"10.1002\/rcm.2592","volume":"20","author":"RV Nirogi","year":"2006","unstructured":"Nirogi RV, Kandikere VN, Shukla M, Mudigonda K, Maurya S. Quantification of tizanidine in human plasma by liquid chromatography coupled to tandem mass spectrometry. Rapid Commun Mass Spectrom. 2006;20:2286\u201392.","journal-title":"Rapid Commun Mass Spectrom"},{"key":"1751_CR23","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.farma.2010.12.008","volume":"36","author":"L Santos","year":"2012","unstructured":"Santos L, Heineck I. Drug utilization study in pediatric prescriptions of a university hospital in southern Brazil: off-label, unlicensed and high-alert medications. Farm Hosp. 2012;36:180\u20136.","journal-title":"Farm Hosp"},{"key":"1751_CR24","doi-asserted-by":"crossref","unstructured":"Mcmanus M. Medical management of spasticity in children with cerebral palsy. Cerebral Palsy. 2019:1\u201310.","DOI":"10.1007\/978-3-319-50592-3_41-1"},{"key":"1751_CR25","doi-asserted-by":"publisher","first-page":"397","DOI":"10.2165\/11316090-000000000-00000","volume":"11","author":"HR Henney","year":"2009","unstructured":"Henney HR, Chez M. Pediatric safety of tizanidine. Paediatr Drugs. 2009;11:397\u2013406.","journal-title":"Paediatr Drugs"},{"key":"1751_CR26","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1007\/BF02731118","volume":"72","author":"DR Patel","year":"2005","unstructured":"Patel DR, Soyode O. Pharmacologic interventions for reducing spasticity in cerebral palsy. Indian J Pediatr. 2005;72:869\u201372.","journal-title":"Indian J Pediatr"},{"key":"1751_CR27","first-page":"30","volume":"99","author":"IL Brin","year":"1999","unstructured":"Brin IL, Kurenkov AL, Gotlib V. The use of sirdalud in cerebral palsy in children. Zh Nevrol Psikhiatr Im S S Korsakova. 1999;99:30\u20133.","journal-title":"Zh Nevrol Psikhiatr Im S S Korsakova"},{"key":"1751_CR28","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.spen.2004.01.008","volume":"11","author":"AH Tilton","year":"2004","unstructured":"Tilton AH. Management of spasticity in children with cerebral palsy. Semin Pediatr Neurol. 2004;11:58\u201365.","journal-title":"Semin Pediatr Neurol"},{"key":"1751_CR29","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1157\/13120053","volume":"68","author":"GR Palazon","year":"2008","unstructured":"Palazon GR, Benavente VA, Arroyo RO. Protocol for tizanidine use in infantile cerebral palsy. An Pediatr (Barc). 2008;68:511\u20135.","journal-title":"An Pediatr (Barc)"},{"key":"1751_CR30","first-page":"19","volume":"5","author":"A Nikkhah","year":"2011","unstructured":"Nikkhah A, Mohammadi M, Ashrafi MR, Zamani GH. The efficacy and safety of tizanidine in treating spasticity in children with cerebral palsy. Iran J Child Neurol. 2011;5:19\u201322.","journal-title":"Iran J Child Neurol"},{"key":"1751_CR31","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1345\/aph.18154","volume":"33","author":"MC Nahata","year":"1999","unstructured":"Nahata MC. Pediatric drug formulations: challenges and potential solutions. Ann Pharmacother. 1999;33:247\u20139.","journal-title":"Ann Pharmacother"},{"key":"1751_CR32","first-page":"734","volume":"28","author":"MP Tagliari","year":"2009","unstructured":"Tagliari MP, Stulzer HK, Assreuy J, Bresolin TMB, Silva MAS. Evaluation of physicochemical characteristics of suspensions containing hydrochlorothiazide developed for pediatric use. Lat Am J Pharm. 2009;28:734\u201340.","journal-title":"Lat Am J Pharm"},{"key":"1751_CR33","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.ejps.2016.05.019","volume":"92","author":"AC Van der Vossen","year":"2016","unstructured":"Van der Vossen AC, Van der Velde I, Smeets OSNM, Postma DJ, Vermes A, Koch BCP, et al. Design and stability study of an oral solution of amlodipine besylate for pediatric patients. Eur J Pharm Sci. 2016;92:220\u20133.","journal-title":"Eur J Pharm Sci"},{"key":"1751_CR34","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.ijpharm.2015.04.016","volume":"487","author":"S Vrignaud","year":"2015","unstructured":"Vrignaud S, Briot T, Launay A, Kempf M, Lagarce F. Design and stability study of a paediatric oral solution of methotrexate 2 mg\/ml. Int J Pharm. 2015;487:270\u20133.","journal-title":"Int J Pharm"},{"key":"1751_CR35","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1080\/00401706.1960.10489912","volume":"2","author":"GEP Box","year":"1960","unstructured":"Box GEP, Behnken DW. Some new three level designs for the study of variables quantitative. Technometrics. 1960;2:455\u201375.","journal-title":"Technometrics."},{"key":"1751_CR36","unstructured":"Gobetti C. Avalia\u00e7\u00e3o da estabilidade de deriva\u00e7\u00e3o farmac\u00eautica hospitalar de tizanidina. 2017;134 f."},{"key":"1751_CR37","unstructured":"ICH. Q2B(R1). Validation of analytical procedures: Methodology. 2005."},{"key":"1751_CR38","unstructured":"Brazilian Pharmacopoeia. 5th ed. 2010."},{"key":"1751_CR39","volume-title":"Pharmaceutics: dosage form and design","author":"D Jones","year":"2008","unstructured":"Jones D. Pharmaceutics: dosage form and design. London: Pharmaceutical Press; 2008."}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-020-01751-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12249-020-01751-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-020-01751-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,28]],"date-time":"2021-07-28T23:05:54Z","timestamp":1627513554000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12249-020-01751-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,29]]},"references-count":39,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["1751"],"URL":"https:\/\/doi.org\/10.1208\/s12249-020-01751-8","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,29]]},"assertion":[{"value":"21 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}],"article-number":"210"}}